Diagnostic Contract Manufacturing Market Performance Outlook 2026–2030: Revenue to Hit $66.08 Billion at 12.7% CAGR
Uncover key drivers, emerging technologies, and competitive movements shaping the diagnostic contract manufacturing market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Diagnostic Contract Manufacturing Market in 2030?
The diagnostic contract manufacturing market has witnessed rapid growth in its size over recent years. It is anticipated to expand from $35.81 billion in 2025 to $40.95 billion in 2026, progressing at a compound annual growth rate (CAGR) of 14.4%. This historical growth can be attributed to several key factors, including the high capital requirements for in-house manufacturing, the complexity of regulations, an increasing number of diagnostic product launches, the demand for manufacturing flexibility, and the globalization of supply chains.
The diagnostic contract manufacturing market size is projected for substantial expansion in the coming years. Its valuation is set to reach $66.08 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.7%. Factors contributing to this growth during the projected timeframe include advancements in diagnostic innovation, the necessity for quick scale-up, the integration of automation, the broadening of regional manufacturing, and an emphasis on robust supply chains. Key trends for this period encompass a rise in the outsourcing of diagnostic manufacturing, an escalating need for manufacturing services that comply with regulations, the broadening of comprehensive CDMO capabilities, a heightened concentration on cost efficiency and scalability, and the integration of automated and intelligent manufacturing techniques.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=16032&type=smp
What Drivers Are Influencing Production Trends In The Diagnostic Contract Manufacturing Market?
The diagnostic contract manufacturing market is expected to experience growth due to an increasing focus on preventive healthcare. Preventive healthcare involves actions taken to stop the onset or progression of disease, illness, or injury. This emphasis on preventive healthcare stems from rising healthcare costs, evolving healthcare priorities, an increase in chronic diseases, and an aging population. Diagnostic contract manufacturing contributes to this increased focus on preventive healthcare by providing crucial diagnostic tools and tests, offering tailored solutions, ensuring quality and regulatory compliance, supporting scalability, and enabling cost-effective options for disease prevention and early intervention. For instance, in October 2025, according to Eurostat, a Luxembourg-based government agency, preventive care was the next largest category, accounting for 3.7% of all healthcare spending in the EU in 2023. Among member states, its share was highest in the Netherlands (5.2%) and lowest in Malta (0.9%). Consequently, the increasing importance of preventive healthcare is driving the expansion of the diagnostic contract manufacturing market.
Which Segment Groups Are Influencing The Diagnostic Contract Manufacturing Market?
The diagnostic contract manufacturing market covered in this report is segmented –
1) By Service: Device Development And Manufacturing Services, Quality Management Services, Packaging And Assembly Services, Other Services
2) By Application: In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Applications
3) By End User: Medical Device Companies, Pharmaceutical And Biopharmaceutical Companies, Other End Users
Subsegments:
1) By Device Development And Manufacturing Services: Product Design And Prototyping, Regulatory Affairs And Compliance, Manufacturing And Assembly, Testing And Validation
2) By Quality Management Services: Quality Control And Assurance, Auditing And Inspection Services, Risk Management, Compliance And Certification Support
3) By Packaging And Assembly Services: Primary Packaging, Secondary Packaging, Sterilization Services, Custom Packaging Solutions
4) By Other Services: Supply Chain Management, Inventory Management, Logistics And Distribution, Aftermarket Services
Which Trends Are Shaping Activity Within The Diagnostic Contract Manufacturing Market?
Leading companies in the diagnostic contract manufacturing market are concentrating on developing advanced solutions, such as one-stop chemiluminescence immunoassay (CLIA) platforms. These efforts aim to enhance assay sensitivity, streamline production workflows, and support the growing demand for high-throughput and precision diagnostic testing. A one-stop CLIA platform represents a fully integrated model, where a contract manufacturer provides everything from core raw materials and reagent development to open-system analyzers and large-scale production capabilities. This differs from traditional segmented manufacturing, where individual components are supplied by various vendors. For instance, in April 2023, Fapon Biotech Inc., a China-based IVD solutions provider, launched its chemiluminescence one-stop solution strategy. This introduction included both compact and high-capacity open-system CLIA analyzers like Shine i1000 and Shine i2000, alongside a portfolio of more than 100 CLIA reagents covering tumor, cardiac, infectious disease, thyroid, and inflammation biomarkers. This solution, designed to help diagnostic companies accelerate product launches and expand testing menus, offers high-quality raw-material sourcing, flexible reagent-development support, reduced per-test costs, and stronger alignment with local manufacturing requirements.
Who Are The Top-Performing Companies In The Diagnostic Contract Manufacturing Market In Recent Years?
Major companies operating in the diagnostic contract manufacturing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Jabil Inc., Flex Ltd., Becton Dickinson and Company (BD), Sekisui Diagnostics LLC, Sanmina Corporation, Celestica Inc., Nipro Medical Corporation, Philips-Medisize Corporation, Plexus Corp, West Pharmaceutical Services Inc., Benchmark Electronics Inc., Bio-Rad Laboratories, QIAGEN N.V., Kimball Electronics Inc., Integer Holdings Corporation, Bio-Techne Corporation, Nolato AB, Nova Biomedical Corporation, Meridian Bioscience Inc., Fujirebio Inc., Biokit S.A., Invetech Pty. Ltd., KMC Systems, Savyon Diagnostics Ltd., Prestige Diagnostics U.K. Ltd., Cenogenic Corporation, Avioq Inc.
Access The Complete Report For Deeper Market Insights:
Which Region Currently Holds The Largest Share Of The Diagnostic Contract Manufacturing Market?
North America was the largest region in the diagnostic contract manufacturing market in 2025. The regions covered in the diagnostic contract manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Diagnostic Contract Manufacturing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=16032&type=smp
Browse Through More Reports Similar to the Global Diagnostic Contract Manufacturing Market 2026, By The Business Research Company
Antibody Contract Manufacturing Market Report 2026
Medical Device Contract Manufacturing Market Report 2026
Contract Development Manufacturing Organizations Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
